ArticleESMO open2025

Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR.

K Ouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.